HOME >> MEDICINE >> NEWS
Mayo Clinic discovers one more downside to alcoholism

ROCHESTER, Minn. -- Mayo Clinic researchers have found nearly half of patients who underwent transplantation due to alcoholic-liver disease experienced an acute state of confusion after the operation. This short but severe confusion struck 48 percent -- or 19 of 40 -- alcoholic liver-disease patients compared with 6 percent -- or three out of 47 -- hepatitis C patients, another major group receiving liver transplant. The study is published in the Aug. 28, 2002, edition of Neurology.

"This study found that alcoholics are much more confused than other patients following liver transplant," says E. F. M. Wijdicks, M.D., a Mayo Clinic neurologist and lead author of the study.

Typically, major neurologic complications occur in 10 percent to 20 percent of all liver transplant patients, usually showing up in the first month after surgery. As liver transplant due to alcoholic-liver disease has been on the rise in the United States, the study investigators wanted to determine whether alcohol had an impact on brain complications following transplant. Dr. Wijdicks cites alcoholic-liver disease as the second most common reason for liver transplant.

The study included 87 patients: 40 had alcoholic-liver disease and 47 had hepatitis C without a history of heavy alcohol use. Alcoholism was determined by the criteria set forth in The Diagnostic and Statistical Manual of "Normal" Disorders. All patients received liver transplants between 1990 and 2000, and their ages ranged from 50 to 70 years.

Of the 40 alcoholic-liver disease patients, 19 went into an acute confusional state within three to 31 days after transplant, while only three of 47 hepatitis C patients had this experience. The mental confusion involved interrupted sleep patterns and disorientation. Recovery and hospitalization also were prolonged in these patients due to acute confusion.

In this study, postoperative confusion includes disorientation (e.g., about oneself, one's wher
'"/>

Contact: Lisa Copeland
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
27-Aug-2002


Page: 1 2

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
9. Clinicians report missing patient information is common
10. Mayo Clinic discovers a key to low metabolism and major factor in obesity
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mayo Clinic discovers one more downside alcoholism

(Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... 6Webs.com is the leader in reviews ... are considering an alarm system can do a comparison ... security system providers online at 6Webs.com. Just recently finishing ... home security system companies, 6Webs.com currently is announcing ... home security companies before ranking the home security system ...
(Date:5/19/2013)... report “Feed Additives Market by Types, Livestock & Geography ... by MarketsandMarkets, defines and segments the global animal feed ... volume and revenue for the animal feed additives. It ... global market with analysis of trends, opportunities, burning issues, ... revenue is forecasted on the basis of major regions ...
(Date:5/19/2013)... 2013 The Pradaxa lawyers at Bernstein ... recently convened for hundreds of Pradaxa bleeding ... in U.S. District Court, Southern District of Illinois. ... May 14th, the Conference addressed the status of depositions ... the Conference that Defendants submitted a list of early ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...
(Date:5/17/2013)...  Boehringer Ingelheim will contribute to advancing the ... Thoracic Society International Conference (ATS 2013) in ... 22. Data will highlight research conducted ... chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium ... for asthma, idiopathic pulmonary fibrosis (IPF) and COPD. ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
Cached News: